☆ 3.8 Article

Point of care testing using rapid automated antigen testing for SARS-COV-2 in care homes - an exploratory safety, usability and diagnostic agreement evaluation

JOURNAL OF PATIENT SAFETY AND RISK MANAGEMENT (2021)

SEeking AnsweRs for Care Homes during the COVID-19 pandemic (COVID SEARCH)

Karen Spilsbury et al.

Summary: The care and support of older people in long-term care facilities during the COVID-19 pandemic has created new uncertainties for staff, with nearly one-third of these uncertainties able to be immediately addressed with fact-based guidance. The remaining uncertainties require long-term research and evidence synthesis.

AGE AND AGEING (2021)

添加到收藏夹

Article Geriatrics & Gerontology

COVID-19 testing in English care homes and implications for staff and residents

Massimo Micocci et al.

Summary: This study identified four main steps in testing pathways in care homes, including infection prevention, preparation, swabbing, and resident management. Swabbing was resource-intensive and challenging for mobile residents with cognitive impairment. Many care homes reported deviating from government guidance to take more cautious approaches in managing post-test situations.

AGE AND AGEING (2021)

添加到收藏夹

Letter Geriatrics & Gerontology

Safe Visiting is Essential for Nursing Home Residents During the COVID-19 Pandemic: An International Perspective

Lee-Fay Low et al.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

SARS-CoV-2 variants and ending the COVID-19 pandemic

Arnaud Fontanet et al.

LANCET (2021)

添加到收藏夹

Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal